You are here: Industry Insights > Manufacturing

News List

Pfizer to improve paediatric medicines manufacturing pharmaceutical-technology
June 21, 2019
Pfizer is set to make an investment in its Discovery Park site in Sandwich, Kent, UK.
Tergus to Build Commercial Manufacturing Facility contractpharma
June 21, 2019
Adds commercial capabilities and will expand current capacity by 400%.
Telix, Eczacıbaşı-Monrol Sign Manufacturing Agreement contractpharma
June 21, 2019
Working together for six months on tech transfer of radiopharmaceutical manufacturing methods for TLX250-CDx.
Patent Covering Manufacturing Process of M-001 Universal Flu Vaccine Allowed in USA, Japan americanpharmaceuticalreview
June 20, 2019
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
Biopharmaceutical contract manufacturing market expected to rise 10.6 percent europeanpharmaceuticalreview
June 20, 2019
A study has predicted that the global biopharmaceutical contract manufacturing market will grow by 10.6 percent from 2017 to 2027.
Adial, Tedor Enter Manufacturing Collaboration contractpharma
June 12, 2019
Adial reaffirms on track to commence phase 3 AD04 trial in Q3 2019.
Trividia Manufacturing Solutions Expands Capabilities contractpharma
June 12, 2019
New tube fill line aims to improve operational efficiency and increase capacity for contract manufacturing of lotions and creams.
Samsung BioLogics: A World Leader in Biopharmaceutical Manufacturing fiercepharma
May 29, 2019
Biopharmaceutical outsourcing for research and development is expected to exceed revenues of $43 billion USD by 2026, as a growing number of pharmaceutical companies turn to independent contract development and manufacturing organizations (CDMOs) to bring
Avid Names Richard Hancock Interim President & CEO contractpharma
May 21, 2019
Industry veteran with over 30 years of operational and executive experience succeeds Roger Lias.
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract En-CPhI.cn
May 21, 2019
WuXi Biologics announced that it has entered into a strategic partnership Letter of Intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page